Avid Bioservices Inc (CDMO)

[keep_trying]

Geo, time is running out for the expression of Pharma interest while working with this BOD, either way. The current BOD may not receive the benefit of the doubt for this proxy vote, absent there being substantive information. If the ASM meeting and proxy vote happen without there having been some clarifying news, interested Pharma will encounter a wild card for negotiating tech rights. They will either be connecting with an invigorated, reelected current BOD augmented by two members (7 total) or encounter a wild card of negotiating with Ronin Directors, who may or may not have designs to sell quickly to a competitor. If Ronin is the honest broker seeking best value for shareholders, any current parties that have been talking to PPHM can expect to lose any negotiating edge they think they developed as they are put back in the pack to start over.

When there are confidentiality agreements associated with business negotiations, communication of the nature you suggest can create cause for litigation. We share holders don't get to know the underlying reasons for the delayed annual shareholder meeting until hindsight comes in focus, perhaps not even then.

Please note that I am not seeking to persuade you on anything here, but you did direct your questions towards me so I am sharing how I see things.

Best wishes and IMO.
KT